Dr Cecilia Johansson is a Reader in Respiratory Immunology in the Section of Respiratory Infections, at the National Heart and Lung Institute, Imperial College London.
Cecilia did her undergraduate studies at Umeå University and Lund University, Sweden. She then did her PhD in the Section for Immunology at Lund University under the supervision of Professor Mary Jo Wick working on Salmonella infection and dendritic cells. She subsequently trained as a postdoctoral fellow with Brian Kelsall at the National Institutes of Health, Bethesda, USA, studying the role of type I interferons (IFNs) during intestinal virus infection.
In 2008, Cecilia set up an independent research group at Imperial College supported initially by a Career Development Award from the Medical Research Council. Her lab focuses on the generation and regulation of immunity via cellular crosstalk in the lung during viral infections. In particular, the lab studies the impact of type I interferons on lung inflammation and how these cytokines influence the induction of both innate and adaptive immune responses. In addition, her lab investigates how respiratory viral infections influence primary and metastatic lung cancer.
Cecilia is an an associate editor for Mucosal Immunology and Frontiers in Immunology (Mucosal Immunology Section). She is a member of the Medical Research Club, Faculty Opinions, Imperial Network for Vaccine Research and the Asthma UK Centre for Asthma and Allergy. She is also a member of the Society for Mucosal Immunology Extramural Programs Committee and their membership committee. Cecilia also organises the Imperial CREST Academy through which Imperial College provides mentors for extracurricular science projects for 16-18 year old students.
Work in Cecilia's laboratory is supported by grants from the MRC, BBSRC, Wellcome Trust, CRUK and the Rosetrees Trust.
et al., 2020, Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection, Science, Vol:370, ISSN:0036-8075, Pages:1-15
et al., 2020, MAVS-deficiency is associated with a reduced T cell response upon secondary RSV infection in mice, Frontiers in Immunology, Vol:11, ISSN:1664-3224
Johansson C, Makris S, 2020, R848 or influenza virus can induce potent innate immune responses in the lungs of neonatal mice, Mucosal Immunology, Vol:14, ISSN:1933-0219, Pages:267-276
et al., 2020, Neutrophils do not impact viral load or the peak of disease severity during RSV infection, Scientific Reports, Vol:10, ISSN:2045-2322
Nuriev R, Johansson C, 2019, Chemokine regulation of inflammation during respiratory syncytial virus infection., F1000res, Vol:8
Makris S, Paulsen M, Johansson C, 2017, Type I interferons as regulators of lung inflammation, Frontiers in Immunology, Vol:8, ISSN:1664-3224
et al., 2017, Protective and Harmful Immunity to RSV Infection, Annual Review of Immunology, Vol:35, ISSN:0732-0582, Pages:501-532
Johansson C, 2016, Respiratory syncytial virus infection: an innate perspective., F1000research, Vol:5, ISSN:2046-1402
et al., 2015, Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes, Journal of Experimental Medicine, Vol:212, ISSN:0022-1007, Pages:699-714
et al., 2014, Alpha/Beta Interferon Receptor Signaling Amplifies Early Proinflammatory Cytokine Production in the Lung during Respiratory Syncytial Virus Infection, Journal of Virology, Vol:88, ISSN:0022-538X, Pages:6128-6136